drugset / Trial / NCT07730554

A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants

NCT07730554 ↗

Phase 2 Active not recruiting 84 enrolled AbbVie
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of AGN-151586 for the treatment of moderate to severe forehead lines (FHL) in adult participants.

Timeline

Start
2026-07-22
Primary completion
2026-10
Completion
2026-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AGN-151586 Unknown — —

Indications

No indication recorded.